Literature DB >> 6358778

Enhanced synthesis, storage, and secretion of insulin in pancreatic islets derived from obese subjects.

H Jahr, K P Ratzmann, R Beckert, W Besch, H J Hahn.   

Abstract

Insulin biosynthesis, content, and secretion were investigated in islets derived from pancreas specimens of normal weight (100.4 +/- 1.1% of ideal body weight) and obese (137.2 +/- 5.9% of ideal weight) patients. The pancreatic islets from the obese subjects were characterized by a significantly enhanced glucose-induced insulin secretion and biosynthesis and by an insulin content that was nearly double when compared with islets from the nonobese subjects. The results support the hypothesis that an enhanced beta-cell reactivity significantly contributes to the insulin hyperresponse observed in the obese state.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6358778     DOI: 10.1016/0026-0495(83)90055-0

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

1.  Correction of obesity and diabetes in genetically obese mice by leptin gene therapy.

Authors:  P Muzzin; R C Eisensmith; K C Copeland; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

2.  Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin.

Authors:  J E Murphy; S Zhou; K Giese; L T Williams; J A Escobedo; V J Dwarki
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

3.  Defective regulation of insulin release and transmembrane Ca2+ fluxes by human islet cell tumours.

Authors:  P R Flatt; S K Swanston-Flatt; C J Powell; V Marks
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

Review 4.  The challenge of correctly reporting hormones content and secretion in isolated human islets.

Authors:  Jean-Claude Henquin
Journal:  Mol Metab       Date:  2019-10-16       Impact factor: 7.422

5.  Neonatal exendin-4 reduces growth, fat deposition and glucose tolerance during treatment in the intrauterine growth-restricted lamb.

Authors:  Kathryn L Gatford; Siti A Sulaiman; Saidatul N B Mohammad; Miles J De Blasio; M Lyn Harland; Rebecca A Simmons; Julie A Owens
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.